Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
26 05 2021
Historique:
received: 29 09 2020
revised: 23 01 2021
accepted: 25 04 2021
pubmed: 5 5 2021
medline: 24 6 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

The rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has gravely affected societies around the world. Outbreaks in different parts of the globe have been shaped by repeated introductions of new viral lineages and subsequent local transmission of those lineages. Here, we sequenced 3940 SARS-CoV-2 viral genomes from Washington State (USA) to characterize how the spread of SARS-CoV-2 in Washington State in early 2020 was shaped by differences in timing of mitigation strategies across counties and by repeated introductions of viral lineages into the state. In addition, we show that the increase in frequency of a potentially more transmissible viral variant (614G) over time can potentially be explained by regional mobility differences and multiple introductions of 614G but not the other variant (614D) into the state. At an individual level, we observed evidence of higher viral loads in patients infected with the 614G variant. However, using clinical records data, we did not find any evidence that the 614G variant affects clinical severity or patient outcomes. Overall, this suggests that with regard to D614G, the behavior of individuals has been more important in shaping the course of the pandemic in Washington State than this variant of the virus.

Identifiants

pubmed: 33941621
pii: scitranslmed.abf0202
doi: 10.1126/scitranslmed.abf0202
pmc: PMC8158963
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIH HHS
ID : S10 OD028685
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM119774
Pays : United States
Organisme : NIH HHS
ID : AI027757
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027757
Pays : United States
Organisme : NIH HHS
ID : R35 GM119774-01
Pays : United States

Commentaires et corrections

Type : UpdateOf

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).

Références

mSphere. 2018 Jun 13;3(3):
pubmed: 29898986
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
PLoS Pathog. 2020 Nov 19;16(11):e1008984
pubmed: 33211775
Cell. 2021 Jan 7;184(1):64-75.e11
pubmed: 33275900
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650
pubmed: 30958812
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Bioinformatics. 2017 Jun 15;33(12):1798-1805
pubmed: 28200071
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Genet Res. 1988 Dec;52(3):213-22
pubmed: 3243426
Am J Respir Crit Care Med. 2020 Jun 1;201(11):1435-1438
pubmed: 32293905
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Science. 2020 Oct 30;370(6516):564-570
pubmed: 32912998
Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
Science. 2020 May 8;368(6491):
pubmed: 32234805
Elife. 2021 Feb 11;10:
pubmed: 33570490
Mol Biol Evol. 2013 Mar;30(3):713-24
pubmed: 23180580
Curr Protoc Bioinformatics. 2020 Mar;69(1):e96
pubmed: 32162851
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
J Clin Microbiol. 2016 Dec 28;55(1):177-182
pubmed: 27795347
Lancet Infect Dis. 2020 May;20(5):553-558
pubmed: 32171059
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Mol Biol Evol. 2013 Jun;30(6):1480-93
pubmed: 23505043
Nat Commun. 2020 Nov 25;11(1):5986
pubmed: 33239633
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):228-33
pubmed: 23248286
Cell Rep. 2020 Nov 3;33(5):108352
pubmed: 33113345
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Comput Appl Biosci. 1997 Jun;13(3):235-8
pubmed: 9183526
J Clin Microbiol. 2020 Jul 23;58(8):
pubmed: 32493788
Syst Biol. 2018 Jul 1;67(4):719-728
pubmed: 29432602
J Clin Virol. 2020 Aug;129:104523
pubmed: 32623351
Science. 2020 Oct 30;370(6516):571-575
pubmed: 32913002
PeerJ. 2020 Sep 16;8:e9473
pubmed: 32995072
Clin Infect Dis. 2021 May 18;72(10):e685-e686
pubmed: 32785682

Auteurs

Nicola F Müller (NF)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. nicola.felix.mueller@gmail.com tbedford@fredhutch.org.

Cassia Wagner (C)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Chris D Frazar (CD)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Pavitra Roychoudhury (P)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Jover Lee (J)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Louise H Moncla (LH)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Benjamin Pelle (B)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Matthew Richardson (M)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Erica Ryke (E)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Hong Xie (H)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Lasata Shrestha (L)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Amin Addetia (A)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Victoria M Rachleff (VM)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Nicole A P Lieberman (NAP)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Meei-Li Huang (ML)

Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Romesh Gautom (R)

Washington State Department of Health, Shoreline, WA 98155, USA.

Geoff Melly (G)

Washington State Department of Health, Shoreline, WA 98155, USA.

Brian Hiatt (B)

Washington State Department of Health, Shoreline, WA 98155, USA.

Philip Dykema (P)

Washington State Department of Health, Shoreline, WA 98155, USA.

Amanda Adler (A)

Seattle Children's Research Institute, Seattle, WA 98101, USA.

Elisabeth Brandstetter (E)

Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.

Peter D Han (PD)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Kairsten Fay (K)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Misja Ilcisin (M)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Kirsten Lacombe (K)

Seattle Children's Research Institute, Seattle, WA 98101, USA.

Thomas R Sibley (TR)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

Melissa Truong (M)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.

Caitlin R Wolf (CR)

Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.

Michael Boeckh (M)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.

Janet A Englund (JA)

Seattle Children's Research Institute, Seattle, WA 98101, USA.
Department of Pediatrics, University of Washington, Seattle, WA 98105, USA.

Michael Famulare (M)

Institute for Disease Modeling, Bellevue, WA 98105, USA.

Barry R Lutz (BR)

Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
Department of Bioengineering, University of Washington, Seattle, WA 98105, USA.

Mark J Rieder (MJ)

Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.

Matthew Thompson (M)

Department of Global Health, University of Washington, Seattle, WA 98195, USA.

Jeffrey S Duchin (JS)

Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
Public Health - Seattle & King County, Seattle, WA98121, USA.

Lea M Starita (LM)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.

Helen Y Chu (HY)

Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.

Jay Shendure (J)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
Howard Hughes Medical Institute, Seattle, WA 98195, USA.

Keith R Jerome (KR)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Scott Lindquist (S)

Washington State Department of Health, Shoreline, WA 98155, USA.

Alexander L Greninger (AL)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA 98195, USA.

Deborah A Nickerson (DA)

Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.

Trevor Bedford (T)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA. nicola.felix.mueller@gmail.com tbedford@fredhutch.org.
Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH